Type 2 Diabetes

Mild autonomous cortisol secretion is prevalent in nearly half of adults with benign adrenal tumors and can increase the risk for hypertension and type 2 diabetes, according to study data published in the Annals of Internal Medicine.

Type 2 diabetes incidence rates do not differ between transgender adults after starting hormone therapy and cisgender adults, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Rates for suicide and mortality were elevated for patients diagnosed with major depressive disorder regardless of timing for diagnosis of type 2 diabetes, according to a longitudinal study published in the Journal of Clinical Psychiatry.

Arterial stiffness in adolescence may be a causal risk factor for hyperinsulinemia and insulin resistance in young adulthood, driving risk for incident type 2 diabetes, according to research published in Hypertension.

Regardless of baseline eGFR, non-albuminuric diabetic kidney disease correlated with increased risks of hospitalization for heart failure and chronic kidney disease progression.

The military experience of veterans with type 2 diabetes may contribute to their diabetes distress and should be considered by providers when discussing diabetes self-management, according to study findings.

The American Diabetes Association recently issued its 2022 Standards of Care, which includes recommendations for screening and first-line therapy. It was the top story in Endocrinology last week.

Clinicians must use multifaceted tools to reduce CV risk in type 2 diabetes, combining newer therapies with efforts to address social determinants of health, according to a new American Heart Association scientific statement.

Health care costs remained high for Medicare beneficiaries with common chronic conditions for which brand-name medications without generic alternatives were recommended, according to findings published in JAMA Internal Medicine.